# Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms

Source: https://onco.cc/trials/nct01761968/  
OnCo record `nct01761968` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Givinostat in myeloproliferative neoplasms, run by Italfarmaco, active and no longer recruiting.

## Summary

Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms is a phase 2 interventional study registered as NCT01761968 by Italfarmaco, with 90 participants enrolled, started 2013-03 and due to reach its primary completion in 2026-12. Interventions recorded: givinostat.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT01761968
- Phase: 2
- Setting: Long-term Study Evaluating the Effect of Givinostat in Patients With JAK2V617F Positive Chronic Myeloproliferative Neoplasms
- Sponsor: Italfarmaco
- Enrolled: 90

## Sources

- ClinicalTrials.gov NCT01761968: https://clinicaltrials.gov/study/NCT01761968

## Connected records

- cancers: [Myeloproliferative neoplasms (PV, ET, myelofibrosis)](https://onco.cc/cancers/myeloproliferative-neoplasms/)
- drugs: [Givinostat](https://onco.cc/drugs/givinostat/)
- companies: [Italfarmaco](https://onco.cc/companies/italfarmaco/)

---
JSON: https://onco.cc/api/v1/entities/nct01761968.json